van Hooren, Luuk <br/><br/>
Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer.  [electronic resource] 

 -  European journal of immunology  02 2017 
 - 385-393 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-4141 
<br/><br/><label>Standard No.: </label>10.1002/eji.201646583  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>CTLA-4 Antigen--immunology<br/>Cell Line, Tumor<br/>Cytokines--metabolism<br/>Drug Therapy, Combination<br/>Growth Inhibitors--therapeutic use<br/>Immunotherapy--methods<br/>Lymphocyte Depletion<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Neoplasm Transplantation<br/>Neoplasms, Experimental<br/>Programmed Cell Death 1 Receptor--immunology<br/>T-Lymphocytes, Regulatory--immunology<br/>Urinary Bladder Neoplasms--immunology